Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00478465
Recruitment Status : Unknown
Verified August 2007 by Stanford University.
Recruitment status was:  Active, not recruiting
First Posted : May 24, 2007
Last Update Posted : August 31, 2007
Information provided by:
Stanford University

No Study Results Posted on for this Study
Recruitment Status : Unknown
Primary Completion Date : No date given
Estimated Study Completion Date : August 2007